Entrada Therapeutics Grants Stock Options and RSUs to New Employees Under 2025 Inducement Plan
I'm PortAI, I can summarize articles.
Entrada Therapeutics Inc. has granted 40,650 RSUs and options to purchase 38,850 shares to five new non-executive employees under the 2025 Inducement Equity Plan. The stock options have an exercise price of $9.91 per share. Vesting occurs over four years, contingent on continued employment. This information was published via GlobeNewswire on December 04, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments